Cargando…

The Emerging Concern and Interest SARS-CoV-2 Variants

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for coronavirus disease 2019 (COVID-19) was discovered in December 2019 in Wuhan, China. Since that time, the virus has spread around the world, which resulted in an announcement of the World Health Organization (WHO), date...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janik, Edyta, Niemcewicz, Marcin, Podogrocki, Marcin, Majsterek, Ireneusz, Bijak, Michal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224338/ https://www.ncbi.nlm.nih.gov/pubmed/34064143 http://dx.doi.org/10.3390/pathogens10060633

Ejemplares similares

Existing Drugs Considered as Promising in COVID-19 Therapy
por: Janik, Edyta, et al.
Publicado: (2021)

SARS-CoV-2: Outline, Prevention, and Decontamination
por: Janik, Edyta, et al.
Publicado: (2021)

T-2 Toxin—The Most Toxic Trichothecene Mycotoxin: Metabolism, Toxicity, and Decontamination Strategies
por: Janik, Edyta, et al.
Publicado: (2021)

The Existing Methods and Novel Approaches in Mycotoxins’ Detection
por: Janik, Edyta, et al.
Publicado: (2021)

Immunosensors—The Future of Pathogen Real-Time Detection
por: Janik-Karpinska, Edyta, et al.
Publicado: (2022)

Healthcare Waste—A Serious Problem for Global Health
por: Janik-Karpinska, Edyta, et al.
Publicado: (2023)

The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2021)

Dangerous Pathogens as a Potential Problem for Public Health
por: Janik, Edyta, et al.
Publicado: (2020)

Various Aspects of a Gene Editing System—CRISPR–Cas9
por: Janik, Edyta, et al.
Publicado: (2020)

Molecular Aspects of Mycotoxins—A Serious Problem for Human Health
por: Janik, Edyta, et al.
Publicado: (2020)

Mitochondrial Damage Induced by T-2 Mycotoxin on Human Skin—Fibroblast Hs68 Cell Line
por: Janik-Karpinska, Edyta, et al.
Publicado: (2023)

DNA Damage Induced by T-2 Mycotoxin in Human Skin Fibroblast Cell Line—Hs68
por: Janik-Karpinska, Edyta, et al.
Publicado: (2023)

Ochratoxin A—The Current Knowledge Concerning Hepatotoxicity, Mode of Action and Possible Prevention
por: Więckowska, Magdalena, et al.
Publicado: (2023)

Direct T-2 Toxicity on Human Skin—Fibroblast Hs68 Cell Line—In Vitro Study
por: Janik-Karpinska, Edyta, et al.
Publicado: (2022)

The emerging SARS-CoV-2 variants of concern
por: Sanyaolu, Adekunle, et al.
Publicado: (2021)

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
por: Lou, Fuxing, et al.
Publicado: (2021)

On the evolution of SARS-CoV-2 and the emergence of variants of concern
por: Magiorkinis, Gkikas
Publicado: (2023)

SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity
por: Liu, Haolin, et al.
Publicado: (2022)

Evolution of the SARS-CoV-2 genome and emergence of variants of concern
por: Safari, Iman, et al.
Publicado: (2021)

Evolutionary insight into the emergence of SARS-CoV-2 variants of concern
Publicado: (2022)

Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria
por: Olawoye, Idowu B., et al.
Publicado: (2023)

Description of a One-Year Succession of Variants of Interest and Concern of SARS-CoV-2 in Venezuela
por: Jaspe, Rossana C., et al.
Publicado: (2022)

Microarray Profiling of Vaccination-Induced Antibody Responses to SARS-CoV-2 Variants of Interest and Concern
por: Svetlova, Julia, et al.
Publicado: (2022)

Quantitative Mutation Analysis of Genes and Proteins of Major SARS-CoV-2 Variants of Concern and Interest
por: Liang, Fengyi
Publicado: (2023)

SARS-CoV-2 Variants of Concern
por: Choi, Jun Yong, et al.
Publicado: (2021)

Editorial: Revised World Health Organization (WHO) Terminology for Variants of Concern and Variants of Interest of SARS-CoV-2
por: Parums, Dinah V.
Publicado: (2021)

Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
por: Laiton-Donato, Katherine, et al.
Publicado: (2021)

Early detection of emerging SARS-CoV-2 variants of interest for experimental evaluation
por: Wallace, Zachary S., et al.
Publicado: (2022)

SARS-CoV-2 Lambda (C.37): An emerging variant of concern?
por: Darvishi, Mohammad, et al.
Publicado: (2021)

Emerging SARS-CoV-2 variants of concern and potential intervention approaches
por: Khateeb, Jasmin, et al.
Publicado: (2021)

Emerging variants of concern in Saudi Arabian SARS-CoV-2 isolates
por: Al-Sehemi, Abdullah G., et al.
Publicado: (2021)

A Sanger-based approach for scaling up screening of SARS-CoV-2 variants of interest and concern
por: Bezerra, Matheus Filgueira, et al.
Publicado: (2021)

Genome Sequences of SARS-CoV-2 P.1 (Variant of Concern) and P.2 (Variant of Interest) Identified in Uruguay
por: Panzera, Yanina, et al.
Publicado: (2021)

The origin of SARS-CoV-2 variants of concern
por: Burki, Talha
Publicado: (2022)

Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis
por: Thye, Angel Yun-Kuan, et al.
Publicado: (2021)

The Emergence of SARS-CoV-2 Variants of Concern Is Driven by Acceleration of the Substitution Rate
por: Tay, John H, et al.
Publicado: (2022)

New Postmortem Perspective on Emerging SARS-CoV-2 Variants of Concern, Germany
por: Heinrich, Fabian, et al.
Publicado: (2023)

Prediction of putative potential siRNAs for inhibiting SARS-CoV-2 strains, including variants of concern and interest
por: Saba, Abdullah Al, et al.
Publicado: (2022)

A Routine Sanger Sequencing Target Specific Mutation Assay for SARS-CoV-2 Variants of Concern and Interest
por: Lee, Sin Hang
Publicado: (2021)

Special Issue “New Insights into Current and Future Vaccines against SARS-CoV-2 Variants of Concern and Interest”
por: Qu, Bingqian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2mf8odd663r1u7bvb8om580efm